229 related articles for article (PubMed ID: 16260635)
21. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
23. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
Shi J; Zhang YW; Yang Y; Zhang L; Wei L
J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
27. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
Adiarto S; Heiden S; Vignon-Zellweger N; Nakayama K; Yagi K; Yanagisawa M; Emoto N
Life Sci; 2012 Oct; 91(13-14):651-7. PubMed ID: 22365964
[TBL] [Abstract][Full Text] [Related]
28. The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease.
Hartmann S; Ridley AJ; Lutz S
Front Pharmacol; 2015; 6():276. PubMed ID: 26635606
[TBL] [Abstract][Full Text] [Related]
29. Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.
Gross V; Obst M; Kiss E; Janke J; Mazak I; Shagdarsuren E; Müller DN; Langenickel TH; Gröne HJ; Luft FC
J Hypertens; 2004 May; 22(5):997-1005. PubMed ID: 15097241
[TBL] [Abstract][Full Text] [Related]
30. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury.
Noma K; Rikitake Y; Oyama N; Yan G; Alcaide P; Liu PY; Wang H; Ahl D; Sawada N; Okamoto R; Hiroi Y; Shimizu K; Luscinskas FW; Sun J; Liao JK
J Clin Invest; 2008 May; 118(5):1632-44. PubMed ID: 18414683
[TBL] [Abstract][Full Text] [Related]
31. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
[TBL] [Abstract][Full Text] [Related]
32. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
33. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
[TBL] [Abstract][Full Text] [Related]
34. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
[TBL] [Abstract][Full Text] [Related]
36. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
Zhang Y; Yan H; Guang GC; Deng ZR
Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
[TBL] [Abstract][Full Text] [Related]
37. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
[TBL] [Abstract][Full Text] [Related]
38. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart.
Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058
[TBL] [Abstract][Full Text] [Related]
39. Rho-kinase inhibition reverses impaired Ca
Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
[TBL] [Abstract][Full Text] [Related]
40. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
